Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012
This article, published in Pediatrics, describes investigators' assessment of intussusception events reported to the Vaccine Adverse Event Reporting System from 2006 through 2012, following the respective introductions of RotaTeq® (Merck & Co., Inc.) and Rotarix® (GlaxoSmithKline) rotavirus vaccines. Investigators observed a persistent clustering of intussusception reported 3 to 6 days after the first dose of vaccination with RotaTeq®, which could translate to a small increased risk of intussusception. However, they conclude that a small increased risk is outweighed by the benefits of rotavirus vaccination. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Haber P, Patel M, Pan Y, et al.
Visit web page (English)
(Located at pediatrics.aappublications.org)
Citation: Haber P, Patel M, Pan Y, et al. Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012. Pediatrics. 2013;131(6):1042-1049.